292 related articles for article (PubMed ID: 25181508)
41. Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation.
Cao JH; Mulvahill M; Zhang L; Joondeph BC; Dacey MS
Ophthalmology; 2014 Oct; 121(10):1871-6. PubMed ID: 24907061
[TBL] [Abstract][Full Text] [Related]
42. Intravitreal steroids for macular edema.
Grosso A; Panico C
Surv Ophthalmol; 2009; 54(3):426; author reply 426-7. PubMed ID: 19422970
[No Abstract] [Full Text] [Related]
43. [Statement of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on the development, diagnostics and treatment of epiretinal gliosis : Status October 2020].
; ;
Ophthalmologe; 2021 Feb; 118(2):121-138. PubMed ID: 33346894
[No Abstract] [Full Text] [Related]
44. [Uveitic cystoid macular edema: intravitreal triamcinolone].
Feucht M; Sturm V; Weissmann J; Richard G; Pressmar S
Klin Monbl Augenheilkd; 2007 Jan; 224(1):62-5. PubMed ID: 17260323
[TBL] [Abstract][Full Text] [Related]
45. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
46. Course of macular edema in uveitis under medical treatment.
Markomichelakis NN; Halkiadakis I; Pantelia E; Georgalas I; Chrysanthi K; Theodossiadis P; Moschos M; Theodossiadis G; Kouvatseas G
Ocul Immunol Inflamm; 2007; 15(2):71-9. PubMed ID: 17558831
[TBL] [Abstract][Full Text] [Related]
47. [Statement of the Professional Association of German Ophthalmologists (BVA) and German Ophthalmological Society (DOG) on the revision of the advanced training regulations exemplified by emergency treatment: network sectors in order to ensure quality in advanced training : Intersectoral ophthalmology-joint committee of the DOG and BVA. Situation January 2020].
;
Ophthalmologe; 2020 May; 117(5):437-438. PubMed ID: 32124001
[No Abstract] [Full Text] [Related]
48. [Assessment and quality assurance of refractive surgical interventions by the DOG (German Society of Ophthalmology) and the BVA (Professional Association of German Ophthalmologists): Update January 2014].
Kohnen T; Neuhann T; Knorz MC
Ophthalmologe; 2014 Apr; 111(4):320-9. PubMed ID: 24756188
[No Abstract] [Full Text] [Related]
49. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
[TBL] [Abstract][Full Text] [Related]
50. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
[TBL] [Abstract][Full Text] [Related]
51. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
52. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema.
Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R
Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857
[TBL] [Abstract][Full Text] [Related]
53. [Statement by the Transport and Traffic Committee of the German Ophthalmological Society (DOG) : October 2015].
Deutsche Ophthalmologische Gesellschaft
Ophthalmologe; 2016 Feb; 113(2):131-2. PubMed ID: 26785679
[No Abstract] [Full Text] [Related]
54. [Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists on anti-VEGF therapy of retinopathy of prematurity : Released: 18 May 2020].
; ;
Ophthalmologe; 2020 Sep; 117(9):873-885. PubMed ID: 32696195
[No Abstract] [Full Text] [Related]
55. [Topical and systemic corticosteroid therapy for uveitis in childhood].
Thurau SR; Frosch M; Zierhut M; Gümbel H; Heiligenhaus A
Klin Monbl Augenheilkd; 2007 Jun; 224(6):516-9. PubMed ID: 17594623
[TBL] [Abstract][Full Text] [Related]
56. Role of OCT in the diagnosis and management of macular edema from uveitis.
Hunter RS; Skondra D; Papaliodis G; Sobrin L
Semin Ophthalmol; 2012; 27(5-6):236-41. PubMed ID: 23163282
[TBL] [Abstract][Full Text] [Related]
57. Management of macular edema secondary to central retinal vein occlusion: an evidence-based.
Aref AA; Scott IU
Adv Ther; 2011 Jan; 28(1):40-50. PubMed ID: 21153510
[TBL] [Abstract][Full Text] [Related]
58. [Statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on the treatment of disturbing degenerative vitreous opacities : Status 20 November 2019].
; ;
Ophthalmologe; 2020 Jul; 117(7):668-670. PubMed ID: 32415326
[No Abstract] [Full Text] [Related]
59. [Etiopathogenesis in macular edema and therapeutic approach].
Buliga S
Oftalmologia; 2011; 55(4):29-33. PubMed ID: 22642133
[TBL] [Abstract][Full Text] [Related]
60. Intravitreal ketorolac for chronic uveitis and macular edema: a pilot study.
Kim SJ; Doherty TJ; Cherney EF
Arch Ophthalmol; 2012 Apr; 130(4):456-60. PubMed ID: 22491916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
